BioCentury
ARTICLE | Company News

Remedyne, University of California deal

December 9, 2002 8:00 AM UTC

Remedyne received an exclusive worldwide license from the Regents of the University of California to patents covering immune stimulation technology. Therapeutic vaccines using the technology cause the...